Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about XCT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | XCT |
| Key Genes/Proteins | AND, APOPTOSIS, ATG5, AUTOPHAGY, BAX, BCL-2 |
| Related Diseases | Als, ALS, Cancer |
| Related Pathways | Apoptosis, Autophagy |
graph TD
XCT["XCT"]
XCT -->|"regulates"| cystine["cystine"]
XCT -->|"activates"| Tumor["Tumor"]
XCT -->|"transports"| Cancer["Cancer"]
XCT -->|"target for"| Ferroptosis["Ferroptosis"]
XCT -->|"activates"| Parkinson["Parkinson"]
XCT -->|"transports"| Als["Als"]
NRF2["NRF2"] -->|"regulates"| XCT
SLC7A11["SLC7A11"] -->|"encodes"| XCT
Nrf2["Nrf2"] -->|"activates"| XCT
AND["AND"] -->|"transports"| XCT
LC3["LC3"] -->|"activates"| XCT| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:XCT | data_in | dataset_row | 0.00 |
| FERROPTOSIS | inhibits | process | 0.80 |
| oxidative stress | downregulates | process | 0.80 |
| GPX4 | interacts_with | protein | 0.75 |
| cystine | regulates | drug | 0.72 |
| Cancer | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Als | transports | disease | 0.65 |
| Ferroptosis | therapeutic_target | disease | 0.65 |
| Ferroptosis | expressed_in | disease | 0.65 |
| Cancer | transports | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| ROS | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| NCOA4 | expressed_in | gene | 0.60 |
| FERROPTOSIS | expressed_in | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| GPX4 | expressed_in | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| HO-1 | activates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| BCL-2 | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| Oxidative Stress | activates | pathway | 0.60 |
| Autophagy | activates | pathway | 0.60 |
| Mtor | activates | pathway | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| NRF2 | activates | gene | 0.60 |
| Neuron | activates | cell_type | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| ferroptosis | participates_in | pathway | 0.60 |
| FERROPTOSIS | transports | gene | 0.60 |
| CANCER | transports | gene | 0.60 |
| Ferroptosis | transports | pathway | 0.60 |
| MTOR | activates | gene | 0.60 |
| SLC7A11 | therapeutic_target | gene | 0.60 |
| FERROPTOSIS | therapeutic_target | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| COX2 | expressed_in | gene | 0.60 |
| SLC7A11 | transports | gene | 0.60 |
| AND | transports | gene | 0.60 |
| Caspase | activates | protein | 0.60 |
| Α-Synuclein | activates | protein | 0.60 |
| Neuron | expressed_in | cell_type | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:XCT | data_in | dataset_row | 0.00 |
| NRF2 | regulates | protein | 0.85 |
| SLC7A11 | encodes | gene | 0.80 |
| Nrf2 | activates | transcription_factor | 0.70 |
| SLC7A11 | transports | gene | 0.60 |
| AND | transports | gene | 0.60 |
| HO-1 | activates | gene | 0.60 |
| BCL-2 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| SLC7A11 | therapeutic_target | gene | 0.60 |
| FERROPTOSIS | expressed_in | gene | 0.60 |
| FER | expressed_in | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| NCOA4 | expressed_in | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| GPX4 | expressed_in | gene | 0.60 |
| FERROPTOSIS | therapeutic_target | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| COX2 | expressed_in | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Microglial xCT/SLC7A11 Selective Inhibition to Reduce Non-Ce | 0.620 | - | Ferroptosis in ALS and motor neuron dise |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Gandouling protection against brain injury in Wilson's disease via SIR | validation | Hepatolenticular degeneration | 0.900 | 0.00 | TX mice (Wilson's disease mode | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning XCT in their description or question text
No additional research found